Cargando…
Gene delivery by surface immobilization of plasmid to tissue engineering scaffolds
Biomaterial scaffolds that serve as vehicles for gene delivery to promote expression of inductive factors have numerous regenerative medicine applications. In this report, we investigate plasmid delivery from biomaterial scaffolds using a surface immobilization strategy. Porous scaffolds were fabric...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927809/ https://www.ncbi.nlm.nih.gov/pubmed/20485383 http://dx.doi.org/10.1038/gt.2010.79 |
_version_ | 1782185787204304896 |
---|---|
author | Salvay, David M. Zelivyanskaya, Marina Shea, Lonnie D. |
author_facet | Salvay, David M. Zelivyanskaya, Marina Shea, Lonnie D. |
author_sort | Salvay, David M. |
collection | PubMed |
description | Biomaterial scaffolds that serve as vehicles for gene delivery to promote expression of inductive factors have numerous regenerative medicine applications. In this report, we investigate plasmid delivery from biomaterial scaffolds using a surface immobilization strategy. Porous scaffolds were fabricated from poly(lactide-co-glycolide) (PLG), and plasmids were immobilized by drying. In vitro plasmid release indicated that the majority (>70%) of adsorbed plasmid was released within 24 hours and >98% within 3 days; however, in vivo implantation of the scaffolds at the subcutaneous site yielded transgene expression that persisted for at least 28 weeks and was localized to the site of implantation. Histological analysis of DNA-adsorbed scaffolds indicated that macrophages at the scaffold were transfected in the first two weeks following implantation, whereas muscle cells adjacent to the implant primarily expressed the transgene at 4 weeks. In addition to localized gene expression, a secreted protein (human factor IX) was retained at the implant site and not available systemically after 3 days, indicating minimal off-target effects. These findings demonstrate that surface immobilization of plasmid onto microporous PLG scaffolds can produce localized and long-term gene expression in vivo, which may be employed to enhance the bioactivity of scaffolds used for regenerative medicine. |
format | Text |
id | pubmed-2927809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
record_format | MEDLINE/PubMed |
spelling | pubmed-29278092011-03-01 Gene delivery by surface immobilization of plasmid to tissue engineering scaffolds Salvay, David M. Zelivyanskaya, Marina Shea, Lonnie D. Gene Ther Article Biomaterial scaffolds that serve as vehicles for gene delivery to promote expression of inductive factors have numerous regenerative medicine applications. In this report, we investigate plasmid delivery from biomaterial scaffolds using a surface immobilization strategy. Porous scaffolds were fabricated from poly(lactide-co-glycolide) (PLG), and plasmids were immobilized by drying. In vitro plasmid release indicated that the majority (>70%) of adsorbed plasmid was released within 24 hours and >98% within 3 days; however, in vivo implantation of the scaffolds at the subcutaneous site yielded transgene expression that persisted for at least 28 weeks and was localized to the site of implantation. Histological analysis of DNA-adsorbed scaffolds indicated that macrophages at the scaffold were transfected in the first two weeks following implantation, whereas muscle cells adjacent to the implant primarily expressed the transgene at 4 weeks. In addition to localized gene expression, a secreted protein (human factor IX) was retained at the implant site and not available systemically after 3 days, indicating minimal off-target effects. These findings demonstrate that surface immobilization of plasmid onto microporous PLG scaffolds can produce localized and long-term gene expression in vivo, which may be employed to enhance the bioactivity of scaffolds used for regenerative medicine. 2010-05-20 2010-09 /pmc/articles/PMC2927809/ /pubmed/20485383 http://dx.doi.org/10.1038/gt.2010.79 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Salvay, David M. Zelivyanskaya, Marina Shea, Lonnie D. Gene delivery by surface immobilization of plasmid to tissue engineering scaffolds |
title | Gene delivery by surface immobilization of plasmid to tissue engineering scaffolds |
title_full | Gene delivery by surface immobilization of plasmid to tissue engineering scaffolds |
title_fullStr | Gene delivery by surface immobilization of plasmid to tissue engineering scaffolds |
title_full_unstemmed | Gene delivery by surface immobilization of plasmid to tissue engineering scaffolds |
title_short | Gene delivery by surface immobilization of plasmid to tissue engineering scaffolds |
title_sort | gene delivery by surface immobilization of plasmid to tissue engineering scaffolds |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927809/ https://www.ncbi.nlm.nih.gov/pubmed/20485383 http://dx.doi.org/10.1038/gt.2010.79 |
work_keys_str_mv | AT salvaydavidm genedeliverybysurfaceimmobilizationofplasmidtotissueengineeringscaffolds AT zelivyanskayamarina genedeliverybysurfaceimmobilizationofplasmidtotissueengineeringscaffolds AT shealonnied genedeliverybysurfaceimmobilizationofplasmidtotissueengineeringscaffolds |